Jul 23, 2026 by Jack DelaneyBetter Stock for Passive Income: Enbridge with Its 70+ Years of Payouts or Energy Transfer with Its 6.6% Yield?Consistency matters more than a high yield.
Jul 23, 2026 by Jack DelaneyRedwire Stock Is Down 42% Over the Last Year. Trading Under $10, Is Now the Time to Buy the Stock?The dip in the Redwire stock price doesn't make it an automatic buy.
Jul 23, 2026 by Jack DelaneySpaceX Outlook: Where the Stock Price for This $1.5 Trillion Giant Could Land in 2027There's no guarantee SpaceX will reach this $225 target, but it does help investors weigh whether they're willing to deal with the risks to achieve the reward.
Jul 23, 2026 by Jack DelaneyIs an AMD Stock Split Likely After Aug. 4?Even if the chipmaker reports stellar results, the odds of a stock split in 2026 are low.
Jul 22, 2026 by Jack DelaneyMicron Has Entered Into Its Own Bear Market: Is a Stock Split Off the Table for 2026?The memory-chip maker may have plunged from its peak, but investors should not overlook its long-term upside.
Jul 22, 2026 by Jack DelaneyWhat History Says About Stocks That Join the Nasdaq-100 and What It Means for SpaceXThe years ahead will be more important for SpaceX than how it fares in its first few months as a part of the tech-heavy Nasdaq-100 index.
Jul 20, 2026 by Jack DelaneySandisk Sinks 24% in 5 Days -- This $2,500 Projection Suggests It's Not Time to PanicA few rough days shouldn't overshadow Sandisk's potential to reward shareholders over the next several years.
Jul 20, 2026 by Jack DelaneyStock Price Projections and History: The Bullish and Bearish Takes for SpaceX Stock Over the Next 12 MonthsThe bull case is compelling, but history says the downside over the next 12 months could be painful.
Jul 19, 2026 by Jack DelaneyCathie Wood Is Selling This High-Flying Stock. Is It a Buy?Wood's ETFs sell stocks that have had strong runs to pay for other positions.
Jul 19, 2026 by Jack DelaneyAnalysts Project the Oklo Stock Price Will Reach $87 in 2027 -- Is the Risk-to-Reward Scenario Worth It?An investment in Oklo requires patience and may take years to pay off.
Jul 18, 2026 by Jack DelaneyJensen Huang Told CES 2026 That Memory Is Now the Biggest Bottleneck in AI. Micron and Sandisk Have Outperformed Nvidia's Stock Ever Since.Memory and data storage manufacturers can't keep up with AI-driven demand.
Jul 18, 2026 by Jack DelaneyJensen Huang Scores Big in Japan -- Here's How to Follow the Nvidia CEO's Lead as the Country Transforms Into a $124 Billion AI HubThe BOTZ ETF is positioned to benefit as Japan invests in blending AI with robotics.
Jul 17, 2026 by Jack DelaneySandisk Has Surged More Than 3,000% in the Last 12 Months. Could a Stock Split Be Coming?A stock split in 2026 could generate a short-term price boost, but long-term gains will depend on the memory company locking in consistent revenues.
Jul 16, 2026 by Jack DelaneyHere's How Much You'd Have Today if You Invested $5,000 Each in Amazon and Costco 3 Years Ago. The Gains May Surprise You.These two retail giants' stock returns haven't been all that different over the past three years, but one has more upside potential.
Jul 16, 2026 by Jack DelaneyBillionaire Stanley Druckenmiller's Top Holding Isn't Nvidia. Instead, It's This Under-the-Radar Stock That Wall Street Loves.It may not be a familiar name, but Natera has provided better returns than Nvidia over the past 12 months.
Jul 15, 2026 by Jack DelaneyA Red Flag Was Just Raised Ahead of Netflix's July 16 Earnings Report -- Here's What It Means for the Stock PriceSubscriber engagement issues could be a warning flag for investors.
Jul 15, 2026 by Jack DelaneyA $900 SpaceX Stock Price Prediction? Here's What a $5,000 Investment Could Turn Into.The most ambitious bull case for SpaceX stands out from the crowd, but it is a longer-range target.
Jul 14, 2026 by Jack DelaneyCathie Wood's Ark Invest Sold $7.4 Million of BioNTech StockCathie Wood's biotech ETF has largely moved on from the vaccine maker.
Jul 14, 2026 by Jack DelaneyCathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy?Cathie Wood's Ark Genomic Revolution ETF owns $50 million worth of Recursion Pharmaceuticals stock.
Jul 13, 2026 by Jack DelaneyHere's What a $5,000 Investment in SpaceX Could Be Worth by 2028The analyst community is optimistic about SpaceX, but retail investors should look at more than just their price targets when making investment decisions.
